Related Experiment Video

Updated: Jun 7, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells

Emily Omori1, Kunihiro Matsumoto, Songyun Zhu

  • 1Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina 27695-7633, USA.

Cancer Research
|October 21, 2010
PubMed

Insights

Targeting TAK1 kinase in skin tumors increases reactive oxygen species (ROS), leading to tumor cell death and regression. This suggests TAK1 is a promising target for ROS-based cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Transforming growth factor-beta-activated kinase 1 (TAK1) regulates transcription factors and reactive oxygen species (ROS) levels.
  • TAK1 ablation in keratinocytes increases sensitivity to ROS-induced apoptosis.
  • Tumor cells often exhibit higher ROS levels than normal cells.

Purpose of the Study:

  • To investigate the effect of TAK1 ablation in existing skin tumors on ROS levels and tumor cell apoptosis.
  • To determine if targeting TAK1 can induce regression of skin tumors.

Main Methods:

  • Utilized inducible epidermal-specific TAK1 knockout mice.
  • Examined the consequences of TAK1 gene deletion in preexisting skin tumors.
  • Assessed ROS accumulation and apoptosis levels post-TAK1 deletion.

Main Results:

  • Deletion of the TAK1 gene in skin tumors led to significant ROS accumulation.
  • Increased apoptosis was observed in tumor cells following TAK1 gene deletion.
  • Skin tumors completely regressed within 5 to 10 days after TAK1 deletion.
  • Normal skin tissue showed no significant abnormalities after TAK1 gene deletion.

Conclusions:

  • TAK1 kinase is a critical regulator of ROS homeostasis in the skin.
  • Ablation of TAK1 in skin tumors effectively induces ROS-based tumor cell death and regression.
  • TAK1 represents a novel and potentially effective molecular target for ROS-based cancer therapy.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...